Anti-NMT2 Antibody

Raised in rabbit against the human N-myristoyltransferase 2 catalytic enzyme, this polyclonal reagent from Antibodies.com supports research on co-translational protein myristoylation, a lipid modification implicated in colorectal cancer signalling, viral host-factor interactions, and apoptotic pathways. The unconjugated antibody selectively recognises human NMT2, enabling laboratories to probe expression changes in tumour cell lines, primary tissue specimens, and relevant disease model systems.

Validated for Western blot and immunohistochemistry, the antiserum is supplied as a 100 µl vial and enables probing of whole-cell lysates and formalin-fixed paraffin-embedded tissue sections. Best practice is to aliquot upon receipt to limit freeze-thaw cycles and store refrigerated, protected from light. Investigators working on myristoylation pathway dysregulation, NMT substrate profiling, and comparative studies with the paralog NMT1 will find this reagent a versatile primary antibody. For research use only.